[Position Paper for the State of the Art Application of Respiratory Support in Patients with COVID-19 - German Respiratory Society].

Against the background of the pandemic caused by infection with the SARS-CoV-2, the German Society for Pneumology and Respiratory Medicine (DGP e.V.), in cooperation with other associations, has designated a team of experts in order to answer the currently pressing questions about therapy strategies in dealing with COVID-19 patients suffering from acute respiratory insufficiency (ARI).The position paper is based on the current knowledge that is evolving daily. Many of the published and cited studies require further review, also because many of them did not undergo standard review processes.Therefore, this position paper is also subject to a continuous review process and will be further developed in cooperation with the other professional societies.This position paper is structured into the following five topics:1. Pathophysiology of acute respiratory insufficiency in patients without immunity infected with SARS-CoV-22. Temporal course and prognosis of acute respiratory insufficiency during the course of the disease3. Oxygen insufflation, high-flow oxygen, non-invasive ventilation and invasive ventilation with special consideration of infectious aerosol formation4. Non-invasive ventilation in ARI5. Supply continuum for the treatment of ARIKey points have been highlighted as core statements and significant observations. Regarding the pathophysiological aspects of acute respiratory insufficiency (ARI), the pulmonary infection with SARS-CoV-2 COVID-19 runs through three phases: early infection, pulmonary manifestation and severe hyperinflammatory phase.There are differences between advanced COVID-19-induced lung damage and those changes seen in Acute Respiratory Distress Syndromes (ARDS) as defined by the Berlin criteria. In a pathophysiologically plausible - but currently not yet histopathologically substantiated - model, two types (L-type and H-type) are distinguished, which correspond to an early and late phase. This distinction can be taken into consideration in the differential instrumentation in the therapy of ARI.The assessment of the extent of ARI should be carried out by an arterial or capillary blood gas analysis under room air conditions and must include the calculation of the oxygen supply (measured from the variables of oxygen saturation, the Hb value, the corrected values of the Hüfner number and the cardiac output). In principle, aerosols can cause transmission of infectious viral particles. Open systems or leakage systems (so-called vented masks) can prevent the release of respirable particles. Procedures in which the invasive ventilation system must be opened, and endotracheal intubation must be carried out are associated with an increased risk of infection.The protection of personnel with personal protective equipment should have very high priority because fear of contagion must not be a primary reason for intubation. If the specifications for protective equipment (eye protection, FFP2 or FFP-3 mask, gown) are adhered to, inhalation therapy, nasal high-flow (NHF) therapy, CPAP therapy or NIV can be carried out according to the current state of knowledge without increased risk of infection to the staff. A significant proportion of patients with respiratory failure presents with relevant hypoxemia, often also caused by a high inspiratory oxygen fraction (FiO2) including NHF, and this hypoxemia cannot be not completely corrected. In this situation, CPAP/NIV therapy can be administered under use of a mouth and nose mask or a respiratory helmet as therapy escalation, as long as the criteria for endotracheal intubation are not fulfilled.In acute hypoxemic respiratory insufficiency, NIV should be performed in an intensive care unit or in a comparable unit by personnel with appropriate expertise. Under CPAP/NIV, a patient can deteriorate rapidly. For this reason, continuous monitoring with readiness to carry out intubation must be ensured at all times. If CPAP/NIV leads to further progression of ARI, intubation and subsequent invasive ventilation should be carried out without delay if no DNI order is in place.In the case of patients in whom invasive ventilation, after exhausting all guideline-based measures, is not sufficient, extracorporeal membrane oxygenation procedure (ECMO) should be considered to ensure sufficient oxygen supply and to remove CO2.

[1]  Y. Hu,et al.  [Asymptomatic infection of COVID-19 and its challenge to epidemic prevention and control]. , 2020, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi.

[2]  L. Camporota,et al.  COVID-19 pneumonia: different respiratory treatments for different phenotypes? , 2020, Intensive Care Medicine.

[3]  Feng Wang,et al.  Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia , 2020, Journal of Thrombosis and Haemostasis.

[4]  J. Baker,et al.  Case for continuing community NIV and CPAP during the COVID-19 epidemic , 2020, Thorax.

[5]  Yongsheng Li,et al.  Clinical Course and Outcomes of 344 Intensive Care Patients with COVID-19 , 2020, American journal of respiratory and critical care medicine.

[6]  M. Nishimura,et al.  Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations , 2020, The Lancet Respiratory Medicine.

[7]  S. Merler,et al.  Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. , 2020, JAMA.

[8]  A. Tam,et al.  Gastrointestinal Manifestations of SARS-CoV-2 Infection and Virus Load in Fecal Samples From a Hong Kong Cohort: Systematic Review and Meta-analysis , 2020, Gastroenterology.

[9]  M. Huang,et al.  Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2 , 2020, Journal of Thrombosis and Thrombolysis.

[10]  Robert Canelli,et al.  Barrier Enclosure during Endotracheal Intubation , 2020, The New England journal of medicine.

[11]  Tong Li,et al.  [Clinical experience of high-flow nasal cannula oxygen therapy in severe COVID-19 patients]. , 2020, Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences.

[12]  H. Shan,et al.  Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection , 2020, Gut.

[13]  C. Eastin,et al.  Characteristics and Outcomes of 21 Critically Ill Patients with COVID-19 in Washington State , 2020, The Journal of Emergency Medicine.

[14]  D. Diz,et al.  COVID-19, ACE2, and the cardiovascular consequences , 2020, American journal of physiology. Heart and circulatory physiology.

[15]  Massimo Cressoni,et al.  COVID-19 Does Not Lead to a “Typical” Acute Respiratory Distress Syndrome , 2020, American journal of respiratory and critical care medicine.

[16]  Centers for Disease Control and Prevention CDC COVID-19 Response Team Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) — United States, February 12–March 16, 2020 , 2020, MMWR. Morbidity and mortality weekly report.

[17]  Mohammad Madjid,et al.  Potential Effects of Coronaviruses on the Cardiovascular System: A Review. , 2020, JAMA cardiology.

[18]  Tao Guo,et al.  Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19) , 2020, JAMA cardiology.

[19]  W. Gong,et al.  Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. , 2020, JAMA cardiology.

[20]  Daniel S. Chertow,et al.  Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19) , 2020, Critical care medicine.

[21]  L. Brochard,et al.  Lung Recruitability in COVID-19–associated Acute Respiratory Distress Syndrome: A Single-Center Observational Study , 2020, American journal of respiratory and critical care medicine.

[22]  G. Onder,et al.  Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. , 2020, JAMA.

[23]  Mandeep R. Mehra,et al.  COVID-19 illness in native and immunosuppressed states: A clinical–therapeutic staging proposal , 2020, The Journal of Heart and Lung Transplantation.

[24]  A. Urbani,et al.  Molecular basis of COVID-19 relationships in different species: a one health perspective , 2020, Microbes and Infection.

[25]  Dylan H. Morris,et al.  Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1 , 2020, The New England journal of medicine.

[26]  Lu Huang,et al.  Early Clinical and CT Manifestations of Coronavirus Disease 2019 (COVID-19) Pneumonia. , 2020, AJR. American journal of roentgenology.

[27]  Giacomo Grasselli,et al.  Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy: Early Experience and Forecast During an Emergency Response. , 2020, JAMA.

[28]  Xin Zhou,et al.  Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China , 2020, The Journal of Emergency Medicine.

[29]  T. Welte,et al.  Empfehlungen zur intensivmedizinischen Therapie von Patienten mit COVID-19 , 2020, Medizinische Klinik - Intensivmedizin und Notfallmedizin.

[30]  R. Lu,et al.  Detection of SARS-CoV-2 in Different Types of Clinical Specimens. , 2020, JAMA.

[31]  T. Egglin,et al.  Performance of radiologists in differentiating COVID-19 from viral pneumonia on chest CT , 2020, Radiology.

[32]  B. Cowling,et al.  Respiratory virus shedding in exhaled breath and efficacy of face masks , 2020, Nature Medicine.

[33]  Xiang Xie,et al.  COVID-19 and the cardiovascular system , 2020, Nature Reviews Cardiology.

[34]  L. Xia,et al.  Coronavirus Disease 2019 (COVID-19): Role of Chest CT in Diagnosis and Management. , 2020, AJR. American journal of roentgenology.

[35]  Qiurong Ruan,et al.  Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China , 2020, Intensive Care Medicine.

[36]  Jun Liu,et al.  Relation Between Chest CT Findings and Clinical Conditions of Coronavirus Disease (COVID-19) Pneumonia: A Multicenter Study. , 2020, AJR. American journal of roentgenology.

[37]  J. Xiang,et al.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study , 2020, The Lancet.

[38]  Rongchang Chen,et al.  More awareness is needed for severe acute respiratory syndrome coronavirus 2019 transmission through exhaled air during non-invasive respiratory support: experience from China , 2020, European Respiratory Journal.

[39]  Q. Tao,et al.  Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases , 2020, Radiology.

[40]  Ting Yu,et al.  Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study , 2020, The Lancet Respiratory Medicine.

[41]  Heshui Shi,et al.  Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study , 2020, The Lancet Infectious Diseases.

[42]  Zunyou Wu,et al.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. , 2020, JAMA.

[43]  Quanyi Wang,et al.  Viral load of SARS-CoV-2 in clinical samples , 2020, The Lancet Infectious Diseases.

[44]  Jason A. Tetro,et al.  Is COVID-19 receiving ADE from other coronaviruses? , 2020, Microbes and Infection.

[45]  Yicheng Fang,et al.  Sensitivity of Chest CT for COVID-19: Comparison to RT-PCR , 2020, Radiology.

[46]  Dengju Li,et al.  Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia , 2020, Journal of Thrombosis and Haemostasis.

[47]  Min Kang,et al.  SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients , 2020, The New England journal of medicine.

[48]  Jiyuan Zhang,et al.  Pathological findings of COVID-19 associated with acute respiratory distress syndrome , 2020, The Lancet Respiratory Medicine.

[49]  J. Qin,et al.  Pre- and Posttreatment Chest CT Findings: 2019 Novel Coronavirus (2019-nCoV) Pneumonia , 2020, Radiology.

[50]  Yan Zhao,et al.  Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. , 2020, JAMA.

[51]  Yicheng Fang,et al.  CT Manifestations of Two Cases of 2019 Novel Coronavirus (2019-nCoV) Pneumonia , 2020, Radiology.

[52]  F. Hayden,et al.  Critical care management of adults with community-acquired severe respiratory viral infection , 2020, Intensive Care Medicine.

[53]  Ting Yu,et al.  Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study , 2020, The Lancet.

[54]  G. Gao,et al.  A Novel Coronavirus from Patients with Pneumonia in China, 2019 , 2020, The New England journal of medicine.

[55]  Ye-ming Wang,et al.  Association Between Cardiac Injury and Mortality in Hospitalized Patients Infected With Avian Influenza A (H7N9) Virus , 2020, Critical care medicine.

[56]  Ghee Chee Phua,et al.  Rapid Progression to Acute Respiratory Distress Syndrome: Review of Current Understanding of Critical Illness from COVID-19 Infection. , 2020, Annals of the Academy of Medicine, Singapore.

[57]  T. Bein,et al.  Was hat sich seit Publikation der S3-Leitlinie „Invasive Beatmung und Einsatz extrakorporaler Verfahren“ getan? , 2020, Pneumologie.

[58]  M. Kotoda,et al.  Assessment of the potential for pathogen dispersal during high-flow nasal therapy , 2019, Journal of Hospital Infection.

[59]  O. Tsang,et al.  Exhaled air dispersion during high-flow nasal cannula therapy versus CPAP via different masks , 2019, European Respiratory Journal.

[60]  C. Gomersall,et al.  Comparison of high-flow nasal cannula versus oxygen face mask for environmental bacterial contamination in critically ill pneumonia patients: a randomized controlled crossover trial. , 2019, The Journal of hospital infection.

[61]  S. Weber-Carstens,et al.  Mechanical Ventilation and Extracorporeal Membrane Oxygena tion in Acute Respiratory Insufficiency. , 2018, Deutsches Arzteblatt international.

[62]  L. Pisani,et al.  Beyond the guidelines for non-invasive ventilation in acute respiratory failure: implications for practice. , 2018, The Lancet. Respiratory medicine.

[63]  Ji-yu Cao,et al.  Role of qSOFA in predicting mortality of pneumonia , 2018, Medicine.

[64]  F. Rapetti,et al.  Reclassifying Acute Respiratory Distress Syndrome , 2018, American journal of respiratory and critical care medicine.

[65]  F. Mielck,et al.  ARDS – Ein Update – Teil 1: Epidemiologie, Pathophysiologie und Diagnostik , 2018, AINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie.

[66]  L. Brochard,et al.  Predictors of Intubation in Patients With Acute Hypoxemic Respiratory Failure Treated With a Noninvasive Oxygenation Strategy* , 2017, Critical care medicine.

[67]  Jovan Pantelic,et al.  Infectious virus in exhaled breath of symptomatic seasonal influenza cases from a college community , 2017, Proceedings of the National Academy of Sciences.

[68]  S. Keenan,et al.  Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure , 2017, European Respiratory Journal.

[69]  J. Bräunlich,et al.  Nasal highflow eliminates CO2 from lower airways , 2017, Respiratory Physiology & Neurobiology.

[70]  S. Perlman,et al.  Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology , 2017, Seminars in Immunopathology.

[71]  Sangeeta Mehta,et al.  Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016 , 2017, Intensive Care Medicine.

[72]  Arthur Slutsky,et al.  Mechanical Ventilation to Minimize Progression of Lung Injury in Acute Respiratory Failure. , 2017, American journal of respiratory and critical care medicine.

[73]  J. Duan,et al.  Assessment of heart rate, acidosis, consciousness, oxygenation, and respiratory rate to predict noninvasive ventilation failure in hypoxemic patients , 2017, Intensive Care Medicine.

[74]  S. Krüger,et al.  Behandlung von erwachsenen Patienten mit ambulant erworbener Pneumonie und Prävention – Update 2016 , 2016, Pneumologie.

[75]  T. Rea,et al.  Assessment of Clinical Criteria for Sepsis: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). , 2016, JAMA.

[76]  D. Swerdlow,et al.  Clinicopathologic, Immunohistochemical, and Ultrastructural Findings of a Fatal Case of Middle East Respiratory Syndrome Coronavirus Infection in the United Arab Emirates, April 2014 , 2016, The American Journal of Pathology.

[77]  L. Brochard,et al.  Failure of Noninvasive Ventilation for De Novo Acute Hypoxemic Respiratory Failure: Role of Tidal Volume* , 2016, Critical care medicine.

[78]  V. Novack,et al.  Hospital Incidence and Outcomes of the Acute Respiratory Distress Syndrome Using the Kigali Modification of the Berlin Definition. , 2015, American journal of respiratory and critical care medicine.

[79]  V. Gant,et al.  Influenza virus survival in aerosols and estimates of viable virus loss resulting from aerosolization and air-sampling. , 2015, The Journal of hospital infection.

[80]  L. Brochard,et al.  High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. , 2015, The New England journal of medicine.

[81]  M. Curley,et al.  Pediatric Acute Respiratory Distress Syndrome: Consensus Recommendations From the Pediatric Acute Lung Injury Consensus Conference* , 2015, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[82]  Sheng-Hsiu Huang,et al.  Particle Size Concentration Distribution and Influences on Exhaled Breath Particles in Mechanically Ventilated Patients , 2014, PloS one.

[83]  Benjamin J. Cowling,et al.  Aerosol transmission is an important mode of influenza A virus spread , 2013, Nature Communications.

[84]  Chandra Sekhar,et al.  Airflow Dynamics of Human Jets: Sneezing and Breathing - Potential Sources of Infectious Aerosols , 2013, PloS one.

[85]  T. R. Peters,et al.  Exposure to influenza virus aerosols during routine patient care. , 2013, The Journal of infectious diseases.

[86]  A. Bennett,et al.  Influenza Aerosols in UK Hospitals during the H1N1 (2009) Pandemic – The Risk of Aerosol Generation during Medical Procedures , 2013, PloS one.

[87]  Linsey C Marr,et al.  Concentrations and size distributions of airborne influenza A viruses measured indoors at a health centre, a day-care centre and on aeroplanes , 2011, Journal of The Royal Society Interface.

[88]  A. Simonds,et al.  Evaluation of droplet dispersion during non-invasive ventilation, oxygen therapy, nebuliser treatment and chest physiotherapy in clinical practice: implications for management of pandemic influenza and other airborne infections. , 2010, Health technology assessment.

[89]  M. Loeb,et al.  Risk Factors for SARS Transmission from Patients Requiring Intubation: A Multicentre Investigation in Toronto, Canada , 2010, PloS one.

[90]  J. Viale,et al.  Factors associated with noninvasive ventilation failure in postoperative acute respiratory insufficiency: an observational study , 2010, European journal of anaesthesiology.

[91]  J. Sung,et al.  Exhaled Air Dispersion Distances During Noninvasive Ventilation via Different Respironics Face Masks , 2009, Chest.

[92]  T. Welte,et al.  [Management of a new influenza A/H1N1 virus pandemic within the hospital: statement of the German Society of Pneumology]. , 2009, Pneumologie.

[93]  D. Beezhold,et al.  Measurement of airborne influenza virus in a hospital emergency department. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[94]  P. Neumann,et al.  Nicht-invasive Beatmung als Therapie der akuten respiratorischen Insuffizienz , 2008, Pneumologie.

[95]  Benjamin J. Cowling,et al.  Influenza Virus in Human Exhaled Breath: An Observational Study , 2008, PloS one.

[96]  J. Bartlett,et al.  Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[97]  David S. Hui,et al.  Noninvasive Positive-Pressure Ventilation , 2006, Chest.

[98]  P. Fujiwara,et al.  Trends in drug-resistant Mycobacterium tuberculosis in New York City, 1991-2003. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[99]  Bo Zhang,et al.  Multiple organ infection and the pathogenesis of SARS , 2005, The Journal of experimental medicine.

[100]  Jianqi Sun,et al.  Study of SARS Transmission Via Liquid Droplets in Air , 2005, Journal of biomechanical engineering.

[101]  Gerhard Scheuch,et al.  Inhaling to mitigate exhaled bioaerosols. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[102]  W. Sibbald,et al.  Transmission of severe acute respiratory syndrome during intubation and mechanical ventilation. , 2004, American journal of respiratory and critical care medicine.

[103]  S. Walter,et al.  SARS among Critical Care Nurses, Toronto , 2004, Emerging infectious diseases.

[104]  Xin Li,et al.  The clinical pathology of severe acute respiratory syndrome (SARS): a report from China , 2003, The Journal of pathology.

[105]  J. Peiris,et al.  Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study , 2003, The Lancet.

[106]  M. Antonelli,et al.  Predictors of failure of noninvasive positive pressure ventilation in patients with acute hypoxemic respiratory failure: a multi-center study , 2001, Intensive Care Medicine.

[107]  H. Matthys,et al.  [Aerosol distribution pattern of 16 commonly used inhalation instruments]. , 1983, Praxis und Klinik der Pneumologie.

[108]  V. Knight,et al.  Human Influenza Resulting from Aerosol Inhalation , 1966, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[109]  Runsheng Wang,et al.  A retrospective observational study , 2020 .

[110]  Arthur S Slutsky,et al.  Noninvasive Ventilation of Patients with Acute Respiratory Distress Syndrome. Insights from the LUNG SAFE Study , 2017, American journal of respiratory and critical care medicine.

[111]  Arthur S Slutsky,et al.  Acute Respiratory Distress Syndrome The Berlin Definition , 2012 .

[112]  R. Fumagalli,et al.  Acute respiratory failure following pharmacologically induced hyperventilation: an experimental animal study , 2004, Intensive Care Medicine.

[113]  F S Rosenthal,et al.  The size distribution of droplets in the exhaled breath of healthy human subjects. , 1997, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.